scispace - formally typeset
L

Leroy Hood

Researcher at Institute for Systems Biology

Publications -  871
Citations -  135243

Leroy Hood is an academic researcher from Institute for Systems Biology. The author has contributed to research in topics: Gene & Peptide sequence. The author has an hindex of 158, co-authored 853 publications receiving 128452 citations. Previous affiliations of Leroy Hood include Agency for Science, Technology and Research & Stowers Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

Initial sequencing and analysis of the human genome.

Eric S. Lander, +248 more
- 15 Feb 2001 - 
TL;DR: The results of an international collaboration to produce and make freely available a draft sequence of the human genome are reported and an initial analysis is presented, describing some of the insights that can be gleaned from the sequence.
Journal ArticleDOI

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

TL;DR: In vivo, antibody to IL- 17 inhibited chemokine expression in the brain during experimental autoimmune encephalomyelitis, whereas overexpression of IL-17 in lung epithelium caused Chemokine production and leukocyte infiltration, indicating a unique T helper lineage that regulates tissue inflammation.
Journal ArticleDOI

A gas-liquid solid phase peptide and protein sequenator.

TL;DR: A new miniaturized protein and peptide sequenator has been constructed which uses gas phase reagents at the coupling and cleavage steps of the Edman degradation, characterized by a high repetitive yield during the degradation, low reagent consumption, low maintenance requirements, and a degradative cycle time of only 50 min using a complete double cleavage program.
Journal ArticleDOI

Integrated genomic and proteomic analyses of a systematically perturbed metabolic network.

TL;DR: An integrated approach to build, test, and refine a model of a cellular pathway, in which perturbations to critical pathway components are analyzed using DNA microarrays, quantitative proteomics, and databases of known physical interactions, suggests hypotheses about the regulation of galactose utilization and physical interactions between this and a variety of other metabolic pathways.